Imaging, pathology, and the multidisciplinary care team
Bring a printable list of questions to your appointment, or share this page with someone who needs it.
Most basal cell carcinomas (BCCs) are diagnosed with a single skin biopsy and treated with one office procedure. No scans, no specialists, no waiting. When a BCC is advanced — large, deep, recurring after treatment, pressing on nerves, or in a spot where surgery would threaten your sight or your face — the evaluation becomes more involved.
The goal of this workup is to answer three questions before anyone picks a treatment: exactly how far has the tumor grown, what is it doing to the structures around it, and which combination of specialists should be involved. This guide walks through each part of that evaluation so you know what to expect and why each step matters.
A small, new BCC on the cheek can be measured with a ruler and seen in its entirety by the naked eye. An advanced tumor often cannot. It may extend under normal-looking skin, track along a nerve, wrap around cartilage, or sit against bone. Treatment decisions — how wide a surgical margin to take, whether radiation is needed, whether to start medication first — all depend on knowing the true extent of the disease.
A thorough workup also prevents surprises. Discovering mid-surgery that a tumor reaches the eye socket or the skull base is far worse than knowing it beforehand and planning accordingly. The evaluation below is designed to map the tumor completely and bring the right specialists in from the start.
Everything starts with a careful in-person exam, usually by a dermatologist or a Mohs surgeon:
The doctor measures the visible lesion, checks whether it moves freely or feels tethered to deeper tissue, and looks for satellite spots nearby. A tumor that is fixed in place suggests invasion into muscle, cartilage, or bone.
Numbness, tingling, burning pain, a drooping eyelid or lip, double vision, or facial weakness can all signal that the cancer is growing along a nerve (perineural invasion). The doctor tests sensation and muscle movement in the area, because these findings change both the imaging plan and the treatment.
The doctor examines the lymph nodes that drain the area — in the neck, in front of and behind the ear, or under the jaw. A firm or enlarged node near a known BCC is uncommon but is checked at every visit because it would point toward the rare possibility of spread.
The tissue diagnosis drives much of what follows. For advanced disease, the pathology report is read closely for several features:
When the diagnosis is unusual or the slides come from another lab, a second dermatopathologist may re-review them. If a repeat or deeper biopsy is needed to see the full growth pattern, that is done before planning.
Imaging is not routine for BCC. It is added when the clinical exam or pathology raises specific concerns — a tumor whose edges cannot be judged by looking and feeling, suspected involvement of bone or deep tissue, symptoms of nerve involvement, recurrent disease, or a tumor near the eye, nose, or ear.
Scans have limits: very small nerve involvement or thin sheets of tumor can be invisible on imaging, so a normal scan does not always mean the tumor is small. Doctors combine imaging with the exam and pathology rather than relying on any one piece.
Advanced BCC is managed by a group rather than a single doctor. You may not meet everyone on this list, but each has a defined role:
Often the doctor who makes the diagnosis and coordinates the workup. Performs margin-controlled surgery when the tumor is still resectable.
Handles large resections involving cartilage, bone, the parotid gland, or the orbit, and performs lymph node surgery if needed.
Delivers radiation as a primary treatment for inoperable tumors or after surgery when the risk of recurrence is high, such as with perineural invasion.
Prescribes and monitors systemic therapy — hedgehog pathway inhibitors or immunotherapy — when surgery and radiation are not enough.
Interpret the tissue and the scans, and re-review outside material so everyone is working from the same information.
Plans how a large defect will be closed or rebuilt, which sometimes influences the surgical approach itself.
Support side-effect management, transportation and cost concerns, and evaluation for Gorlin syndrome when someone has many BCCs at a young age.
Many centers bring these specialists together at a tumor board — a meeting where a complex case is presented and the group agrees on a recommendation. Your case can be reviewed there without you attending; you then hear the combined plan from your primary doctor.
Once the exam, pathology, and any imaging are complete, the team classifies the tumor as resectable (removable with acceptable function and appearance) or locally advanced and not suitable for surgery or radiation. That classification points toward one of a few paths: surgery alone, surgery followed by radiation, radiation alone, medication before surgery to shrink the tumor, or systemic therapy as the main treatment.
The workup is also the moment to raise clinical trials, fertility or dental care before radiation, and a baseline of your other health conditions. A complete evaluation up front means fewer detours later.
The evaluation for advanced BCC is more thorough than for an ordinary skin cancer because the stakes and the anatomy are more complex. A careful exam, a close read of the pathology, targeted imaging when it is warranted, and input from several specialties together produce a treatment plan built on a complete picture of the tumor.
If any part of your workup feels rushed or unclear, it is reasonable to ask for the tumor to be mapped fully before a treatment decision is made — and to bring a written list of questions to each visit.
Disclaimer: This article is for educational purposes only and not a substitute for professional medical advice. Always consult a qualified dermatologist or oncologist about your personal diagnosis and treatment plan.
Chat with our AI guide for information about how advanced basal cell carcinoma is evaluated
Chat with the Navigator